A review on various heterocyclic moieties and their antitubercular activity

Biomedicine and Pharmacotherapy

Volumn 65, Issue 4, 2011, Pages 244-251

  Sharma, S ^a   Sharma, P K ^a   Kumar, N ^a   Dudhe, R ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Mycobacterium tuberculosis; Pyrazoline; Tuberculosis

Indexed keywords

1 [4 (4 CHLOROPHENYL) 6 (3,4,5 TRIMETHOXYPHENYL)PYRIMIDIN 2 YL UREIDO] 3 CHLORO 4 ARYL 2 AZETIDINONE DERIVATIVE; 2 3 [4 (4 CHLOROPHENYL) 6 (3,4,5 TRIMETHOXY PHENYL)PYRIMIDIN 2 YL UREIDO] 4 THIAZOLIDINONE DERIVATIVE; 2 AZETIDINONE DERIVATIVE; 4 BIS N OXIDE 3 METHYLQUINOXALINE 2 CARBOXYLIC ACID ARYL AMIDE DERIVATIVE; 4 DIMETHYLAMINOPHENYL PURINE; 4 THIAZOLIDINONE DERIVATIVE; 6 (4 METHYOXYPHENYL)PURINE; 6 HETEROARYL 9 BENZYLPURINE DERIVATIVE; ACYLHYDRAZONE; ACYLTHIOSEMICARBAZIDE DERIVATIVE; AZETIDINONE DERIVATIVE; BENZIMIDAZOLE; HETEROCYCLIC COMPOUND; ISONIAZID; OXADIAZOLE DERIVATIVE; PURINE DERIVATIVE; PYRAZINAMIDE; PYRAZOLE; PYRAZOLINE DERIVATIVE; PYRIMIDINE; QUINOLONE DERIVATIVE; QUINOXALINE; QUINOXALINE 1,4 BIS N OXIDE DERIVATIVE; QUINOXALINE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THIAZOLE; THIOZOLIDINONE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIUM CULTURE; BCG VACCINATION; CELL DIVISION; CYTOTOXICITY; CYTOTOXICITY TEST; DISEASE TRANSMISSION; DRUG ANALYSIS; DRUG SYNTHESIS; FALSE NEGATIVE RESULT; GENE EXPRESSION; INCIDENCE; LIFE CYCLE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MYCOBACTERIUM; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CANETTI; MYCOBACTERIUM KANSASII; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM MICROTI; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; TUBERCULIN TEST; TUBERCULOSIS; X RAY;

ANTITUBERCULAR AGENTS; DRUG DESIGN; HETEROCYCLIC COMPOUNDS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TUBERCULOSIS;

EID: 79960437207     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.005     Document Type: Review

References (34)

1. Kumar V., Abbas A.K., Fausto N., Mitchell R.N.R. Robbins basic pathology 2007, Saunders Elsevier, p. 516-522. 8th ed.
2. Konstantinos A. Testing for tuberculosis. Austr Presc 2010, 33:12-18. http://www.australianprescriber.com/magazine/33/1/12/18/.
3. Jasmer R.M., Nahid P., Hopewell P.C. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002, 347(23):1860-1866.
4. " Tuberculosis" World Health Organization., 2007. http://who.int/mediacentre/factsheets/fs104/en/index.html. Retrieved 12 November 2009. Fact sheet No 104.
5. World Health Organization, " Epidemiology" Global tuberculosis control: epidemiology, strategy, financing 2009; 6-33. ISBN 978 92 4 156380 2. http://who.int/entity/tb/publications/global_report/2009/pdf/chapter1.pdf. Retrieved 12 November 2009.
6. Extrapulmonary tuberculosis: an overview Marjorie P. Golden, M.D., Yale university School of Medicine and hospital of Saint Raphael, New Haven, Connecticut. Holenarasipur R. Vikram, M.D., Mayo Clinic, Scottsdale, Arizona.
7. Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination. Core curriculum on tuberculosis: what the clinician should know, 4th ed., 2000. Atlanta, USA, Updated August 2003.
8. Southwick F. Chapter 4: Pulmonary infections" Infectious diseases: a clinical short course 2007, McGraw-Hill Medical Publishing Division, p. 104. 2nd ed.
9. Cox R Quantitative relationships for specific growth rates and macromolecular compositions of Mycobacterium tuberculosis, Streptomyces coelicolor A3 (2) and Escherichia coli B/r: an integrative theoretical approach. Microbiology 2004, 150(Pt 5):1413-1426.
10. Madison B. Application of stains in clinical microbiology. Biotech Histochem 2001, 76(3):119-125.
11. Parish T., Stoker N. Mycobacteria: bugs and bugbears (two steps forward and one step back). Mol Biotechnol 1999, 13(3):191-200.
12. Van Soolingen D., Hoogenboezem T., De Haas P.E. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 1997, 47(4):1236-1245.
13. Niemann S., Rüsch-Gerdes S., Joloba M.L. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol 2002, 40(9):3398-3405.
14. Niobe-Eyangoh S.N., Kuaban C., Sorlin P. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol 2003, 41(6):2547-2553. 10.1128/JCM.41.6.2547-2553.
15. Thoen C., Lobue P., de Kantor I. The importance of Mycobacterium bovis as a zoonosis. Vet Microbiol 2006, 112(2-4):339-345. 10.1016/j.vetmic.2005.11.047.
16. Pfyffer G.E., Auckenthaler R., van Embden J.D., van Soolingen D. Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerging Infect Dis 1998, 4(4):631-634.
17. Niemann S., Richter E., Dalügge-Tamm H., Schlesinger H., Graupner D., Königstein B., et al. Two cases of Mycobacterium microti derived tuberculosis in HIV-negative immunocompetent patients. Emerg Infect Dis 2000, 6(5):539-542.
18. Medical Section of the American Lung Association Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Am J Respir Crit Care Med 1997, 156(2 Pt 2):S1-25.
19. Rothel J., Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?. Expert Rev Anti Infect Ther 2005, 3(6):981-993.
20. Mohamed A.A., Mohammad S., Ahamed Siddiqui A. Synthesis, structural activity relationship and antitubercular activity of novel pyrazoline derivatives. Eur J Med Chem 2007, 42:268-275.
21. Blair I.A., Timoco R.M., Brodie M.J., Clarc R.A., Dollery T., Timbrell J.A., et al. Hum Toxicol 1985, 4:195.
22. Shingalapur R.V., Hosamani K.M., Keri R.S. Synthesis and evaluation of in vitro antimicrobial and antitubercular activity of 2-styryl benzimidazoles. Eur J Med Chem 2009, 44:4244-4248.
23. Khalafi-Nezhad A., Rad M.N.S., Mohbatkar H., Asrari Z., Hemmateenejad B. Bioorg Med Chem 2005, 13:1931-1938.
24. Evans B.E., Rittle K.E., DiPardo R.M., Freidinger R.M., Whitter W.L., Lundell G.F., et al. J Med Chem 1998, 31:2235-2246.
25. Brændvang M., Gundersen L.-L. Selective antitubercular purines: synthesis and chemotherapeutic properties of 6-aryl- and 6-heteroaryl-9-benzylpurines. Bioorg Med Chem 2005, 13:6360-6373.
26. Man-Lin Li, You-Ming, Tai-Bao Wei Synthesis and bioactivity study of 2,5-bismercapto-1,3,4-thiadiazole heterocyclic derivatives. Indian J Chem 2007, 46B:544-549.
27. Pattan S.R., Bukitagar A.A., Pattan J.S., Kapadnis B.P., Jaghav S.G. Synthesis and evaluation of some new substituted phenylthiazole derivatives and there antitubercular activity. Indian J Chem 2009, 48B:1033-1037.
28. Shindikar A.V., Viswanathan C.L. Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv. Bioorg Med Chem Lett 2005, 15:1803-1806.
29. Cozarelli N.R. Science 1980, 207:643.
30. Ancizu S., Moreno E., Solano B., Villar R., Burguete A., Torres E., et al. New 3 methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Bioorg Med Chem 2010, 18:2713-2719.
31. Pattan S.R., Rabara P.A., Pattan J.S., Bukitagar A.A., Wakale V.S., Musmade D.S Synthesis and evaluation of novel substituted 1,3,4-Oxadiazole and pyrazole derivatives for antitubercular activity. Indian J Chem 2009, 48B:1453-1456.
32. Patel R.B., Desai P.S., Desai K.R., Chikhalia K.H. Synthesis of pyrimidine based thiazolidinones and azetidinones: antimicrobial and antitubercular agents. Indian J Chem 2006, 45B:773-778.
33. Narute A.S., Khedekar P.B., Bhusari K.P. QSAR studies on 4-thiazolidinones and 2-azetidinones bearing benzothiophene nucleus as potential antitubercular agent. Indian J Chem 2008, 47B:586-591.
34. Pattan S.R., Krishna Reddy V.V., Manvi B.G., Desai, Bhat A.R. Synthesis of N-3(4-(4-Chlorophenyl thiazole-2-yl)-(2-(amino)methyl)-quinazolines-4(3H)-one and their derivatives for antitubercular activity. Indian J Chem 2006, 45B:1778-1781.